Por: The Hill Health January 16, 2023
Following an analysis of vaccine surveillance data, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) say they have found no evidence of increased risk of ischemic stroke among people 65 and older who receive Pfizer’s bivalent booster. After Pfizer’s updated, bivalent COVID-19 booster dose was made available, the CDC said its Vaccine Safety Datalink prompted additional investigation into concerns... + full article
Forbes USA Business January 14, 2023
Topline The Centers for Disease Control and Prevention and the Food and Drug Administration Friday a possible link has been identified between Pfizer-BioNTech’s bivalent Covid-19 vaccine and ischemic strokes in people over the age of 65 who received the shot, however the... + más
Bivalent booster is 4x better against BA.5 in older adults, Pfizer says | Ars Technica
Moderna says updated booster stronger against omicron subvariants | ABC7
CNBC USA Health January 14, 2023
A patient receives a Covid-19 vaccine booster shot at a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, on Sept. 29, 2021.Emily Elconin ReutersThe Centers for Disease Control and Prevention on Friday said it is very unlikely the Pfizer omicron booster carries a risk... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
Politico USA Health January 13, 2023
The CDC and FDA announced on Friday that their surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance “raised a... + más
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
Ars Technica USA Science December 10, 2022
Navigate Filter by topic Settings Front page layout Site theme - Dec 9, 2022 11:08 pm UTC / Reisa Lancaster RN, left, administers the Covid-19 vaccine to 14 month old Ada Hedge, center, being comforted by mom Sarah Close and dad Chinmay Hedge, right at Children's National... + más
New COVID booster authorization will sway parents to get young kids vaccinated, FDA vaccine chief hopes | ABC News
Politico USA Health December 08, 2022
The FDA on Thursday authorized emergency use of updated bivalent Covid-19 vaccines for children as young as 6 months old. The move to authorize bivalent shots made by Pfizer-BioNTech and Moderna comes as Covid-19 infections in the United States tick up amid the most intense flu... + más
Kids 5-11 can now get the bivalent, BA.5-targeting COVID booster | Ars Technica
FDA authorizes bivalent COVID-19 boosters for children as young as 6 months | WGN-TV
ABC News USA Health October 12, 2022
The U.S. Food and Drug Administration the updated bivalent COVID-19 booster for younger children Wednesday.The Pfizer booster has been authorized for children aged 5 and older and the Moderna booster for children aged 6 and older.When the new boosters were initially authorized... + más
11.5M Americans have received updated COVID booster: CDC | ABC News
4.4 million Americans have received an updated bivalent COVID-19 booster | ABC News
Time USA Health September 24, 2022
A published Sept. 16 in the New England Journal of Medicine (NEJM) makes a strong case for an Omicron-based COVID-19 booster shot. But first, a caveat: There are no data available yet demonstrating the effectiveness of the new Omicron booster on Aug. 31, which protects against... + más
Moderna-backed mouse study offers first head-to-head BA.5, BA.1 booster data | Ars Technica
Here’s How Effective the Original Vaccines Are Against Omicron | Time
About iurex | Privacy Policy | Disclaimer |